Search research articles
Contact Us
Filters
Showing results (51-60 of 113) with videos related to
Page
of 12
Sort By:
Clinical Colorectal Cancer
|
April 8, 2016
Autologous Cytokine-Induced Killer Cells Improves Overall Survival of Metastatic Colorectal Cancer Patients: Results From a Phase II Clinical Trial
Hua Zhao, Yang Wang, Jinpu Yu, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
July 30, 2011
Synergistic effect of CH-296 and interferon gamma on cytokine-induced killer cells expansion for patients with advanced-stage malignant solid tumors
Jinpu Yu, Xiubao Ren, Hui Li, et al.
Annals of Translational Medicine
|
March 14, 2022
Vasohibin 2 promotes lymphangiogenesis of lung squamous cell carcinoma through snail-dependent vascular endothelial growth factor-D (VEGF-D) signaling pathway
Pengpeng Liu, Rui Zhang, Lei Han, et al.
Cancer Science
|
March 1, 2025
Insights From Nonsense-Mediated mRNA Decay for Prognosis in Homologous Recombination-Deficient Ovarian Cancer
Lei Han, Jialing Liu, Runjiao Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 27, 2014
Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer
Jinpu Yu, Yue Wang, Fang Yan, et al.
Journal of Cancer
|
November 22, 2017
Cytokine-Induced Killer Cells Modulates Resistance to Cisplatin in the A549/DDP Cell Line
Lili Yang, Chunjuan Du, Lei Wu, et al.
Cancer Biology & Medicine
|
September 11, 2018
Benefit of everolimus as a monotherapy for a refractory breast cancer patient bearing multiple genetic mutations in the PI3K/AKT/mTOR signaling pathway
Yehui Shi, Wenwen Zhang, Yingnan Ye, et al.
Frontiers in Bioengineering and Biotechnology
|
November 4, 2022
Early myeloid-derived suppressor cells accelerate epithelial-mesenchymal transition by downregulating ARID1A in luminal A breast cancer
Guidong Chen, Xingchen Li, Chenyan Ji, et al.
Frontiers in Immunology
|
November 23, 2017
Herceptin Enhances the Antitumor Effect of Natural Killer Cells on Breast Cancer Cells Expressing Human Epidermal Growth Factor Receptor-2
Xiao Tian, Feng Wei, Limei Wang, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 20, 2013
Immunotherapy with cytokine-induced killer cells as an adjuvant treatment for advanced gastric carcinoma: a retrospective study of 165 patients
Hua Zhao, Yongli Fan, Hui Li, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 113) with videos related to
Sort By:
Page
of 12
Clinical Colorectal Cancer
|
April 8, 2016
Autologous Cytokine-Induced Killer Cells Improves Overall Survival of Metastatic Colorectal Cancer Patients: Results From a Phase II Clinical Trial
Hua Zhao, Yang Wang, Jinpu Yu, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
July 30, 2011
Synergistic effect of CH-296 and interferon gamma on cytokine-induced killer cells expansion for patients with advanced-stage malignant solid tumors
Jinpu Yu, Xiubao Ren, Hui Li, et al.
Annals of Translational Medicine
|
March 14, 2022
Vasohibin 2 promotes lymphangiogenesis of lung squamous cell carcinoma through snail-dependent vascular endothelial growth factor-D (VEGF-D) signaling pathway
Pengpeng Liu, Rui Zhang, Lei Han, et al.
Cancer Science
|
March 1, 2025
Insights From Nonsense-Mediated mRNA Decay for Prognosis in Homologous Recombination-Deficient Ovarian Cancer
Lei Han, Jialing Liu, Runjiao Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 27, 2014
Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer
Jinpu Yu, Yue Wang, Fang Yan, et al.
Journal of Cancer
|
November 22, 2017
Cytokine-Induced Killer Cells Modulates Resistance to Cisplatin in the A549/DDP Cell Line
Lili Yang, Chunjuan Du, Lei Wu, et al.
Cancer Biology & Medicine
|
September 11, 2018
Benefit of everolimus as a monotherapy for a refractory breast cancer patient bearing multiple genetic mutations in the PI3K/AKT/mTOR signaling pathway
Yehui Shi, Wenwen Zhang, Yingnan Ye, et al.
Frontiers in Bioengineering and Biotechnology
|
November 4, 2022
Early myeloid-derived suppressor cells accelerate epithelial-mesenchymal transition by downregulating ARID1A in luminal A breast cancer
Guidong Chen, Xingchen Li, Chenyan Ji, et al.
Frontiers in Immunology
|
November 23, 2017
Herceptin Enhances the Antitumor Effect of Natural Killer Cells on Breast Cancer Cells Expressing Human Epidermal Growth Factor Receptor-2
Xiao Tian, Feng Wei, Limei Wang, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 20, 2013
Immunotherapy with cytokine-induced killer cells as an adjuvant treatment for advanced gastric carcinoma: a retrospective study of 165 patients
Hua Zhao, Yongli Fan, Hui Li, et al.
Page
of 12